Flupentixol Hydrochloride is a potent antipsychotic medication belonging to the typical antipsychotic (neuroleptic) class, specifically the thioxanthene group. Its primary mechanism of action involves antagonizing
dopamine receptors in the brain, predominantly the
D2 receptors. This antagonism is crucial in mitigating symptoms associated with
schizophrenia and other
psychotic disorders.
Dopamine is a neurotransmitter that plays a significant role in mood regulation, cognition, and behavior. In conditions like schizophrenia, it is believed that there is an overactivity of dopamine transmission, particularly in the mesolimbic pathway, which contributes to the positive symptoms of the disorder, such as
hallucinations and
delusions. By blocking D2 receptors, Flupentixol Hydrochloride reduces this hyperactivity, thereby helping to alleviate these symptoms.
Additionally, Flupentixol Hydrochloride has moderate antagonistic effects on serotonin (5-HT2),
histamine (H1), and
alpha-adrenergic receptors. The
serotonin receptor antagonism can contribute to the reduction of both positive and negative symptoms of psychosis, while histamine and alpha-adrenergic receptor blocking can lead to sedative effects and help manage
anxiety and
agitation.
However, the blockade of these receptors also leads to various side effects. For instance, the dopamine receptor antagonism can cause
extrapyramidal symptoms (EPS), which are
drug-induced movement disorders, including
tremors,
rigidity, bradykinesia, and
tardive dyskinesia. The antagonism of
histamine receptors can lead to
sedation and weight gain, while alpha-adrenergic receptor blockade can cause
hypotension and
dizziness.
Flupentixol Hydrochloride is available in both oral and injectable forms. The injectable form, often used in long-acting depot injections, provides sustained release of the drug, ensuring compliance in patients who may have difficulty adhering to daily medication regimens.
In summary, the mechanism of Flupentixol Hydrochloride primarily revolves around its antagonistic effects on dopamine D2 receptors, which helps manage the symptoms of schizophrenia and other psychotic disorders by reducing dopamine overactivity. Its interactions with other neurotransmitter receptors also contribute to its therapeutic and side effect profile, making it a multifaceted drug in the management of mental health conditions.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


